Sensidose is a pharmaceutical company. The company has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The company's product portfolio includes a number of brands and drugs intended for the treatment of, for example, Parkinson's. The main operations are in the Nordic region.

Quotes for Sensidose Aktiebolag

+/-
%
()

Board

CEO

  • Jack Spira

Chairperson of the Board

  • Kathrine Gamborg Andreassen

Board

  • Jostein Davidsen
  • Lars Hjarrand
  • Tony Brejke